NASDAQ · AYTU
Aytu BioPharma, Inc.
$1.98+$0.01 (+0.51%)
Aytu BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.5% below the high.
Loading market information…
NASDAQ · GELS · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Gelteq Limited Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 74.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.98+$0.01 (+0.51%)
Aytu BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.5% below the high.
$0.98-$0.01 (-1.01%)
Cocrystal Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.72% below the high.
$0.93+$0.05 (+5.09%)
Biofrontera Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.89% below the high.
$0.51+$0.02 (+3.88%)
Bullfrog AI Holdings, Inc. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 74.18% below the high.
$3.33+$0.22 (+7.07%)
Sunshine Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.28% below the high.
$0.92+$0.02 (+2.48%)
Immuron Limited’s quoted price sits in the lower half of its reported 52-week range, 56.69% below the high.
$0.83+$0.00 (+0.35%)
Imunon, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.61% below the high.
$0.38+$0.01 (+1.6%)
Evogene Ltd.’s quoted price sits in the lower half of its reported 52-week range, 70.74% below the high.
